Analyst Expect Big Moves From Boston Scientific Corp (NYSE: BSX)

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 2.23% and 15.25% over the past three months. BSX shares are trading 56.46% year to date (YTD), with the 12-month market performance up to 65.45% higher. […]

Boston Scientific Corp (NYSE: BSX): Analyst View Points To Future Growth

Boston Scientific Corp (BSX) concluded trading on Wednesday at a closing price of $88.77, with 4.17 million shares of worth about $370.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.23% during that period and on November 13, 2024 the price saw a […]

Boston Scientific Corp (BSX) Testing Investors’ Patience Right Now

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of -0.05% and 14.86% over the past three months. BSX shares are trading 46.55% year to date (YTD), with the 12-month market performance up to 61.31% higher. […]

Boston Scientific Corp. (NYSE: BSX) Has Another Chance To Impress You

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of -3.74% and 14.49% over the past three months. BSX shares are trading 46.62% year to date (YTD), with the 12-month market performance up to 70.27% higher. […]

Boston Scientific Corp. (NYSE: BSX) – Suitable For Long Term Buy?

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 0.57% and 12.04% over the past three months. BSX shares are trading 52.31% year to date (YTD), with the 12-month market performance up to 74.18% higher. […]

Boston Scientific Corp. (NYSE: BSX) – Suitable For Long Term Buy?

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 3.72% and 12.04% over the past three months. BSX shares are trading 51.44% year to date (YTD), with the 12-month market performance up to 80.00% higher. […]

These Numbers Could Change Investor Views For Boston Scientific Corp. (NYSE: BSX)

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 0.73% and 10.33% over the past three months. BSX shares are trading 46.01% year to date (YTD), with the 12-month market performance up to 63.33% higher. […]

These Numbers Could Change Investor Views For Boston Scientific Corp. (NYSE: BSX)

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 0.75% and 9.92% over the past three months. BSX shares are trading 45.55% year to date (YTD), with the 12-month market performance up to 59.36% higher. […]

Reassessing The Changing Outlook For Boston Scientific Corp. (BSX)

Currently, there are 1.47B common shares owned by the public and among those 1.47B shares have been available to trade. The company’s stock has a 5-day price change of 1.20% and 7.74% over the past three months. BSX shares are trading 44.46% year to date (YTD), with the 12-month market performance up to 55.80% higher. […]

Boston Scientific Corp. (NYSE: BSX) Has Another Chance To Impress You

Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 106 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 58 of these insider trades were purchases, […]